Assessment of antihyperlipidemic therapy in US patients with coronary heart disease

Journal of the American Osteopathic Association

Volumn 110, Issue 6, 2010, Pages 331-339

  Moser, Ashley ^a   Segars, Larry W ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b University of Medicine and Biosciences (KCUMB)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FACTUAL DATABASE; FEMALE; HEALTH CARE SURVEY; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK; RISK FACTOR; UNITED STATES;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 77954733204     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lloyd-Jones D, Adams R, Carnethon H, De Simone G, Ferguson B, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published online ahead of print December 15, 2008]. Circulation. 2009;119(3):e21-e181. http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.108.191261v1.pdf. Accessed March 20, 2009.
2. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med. 1990;322 (24):1700-1707.
3. American Heart Association. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report [published online ahead of print September 2002]. Circulation. 2002;106(25):3143-3421. http://circ.ahajournals.org/cgi/reprint/106/25/3143. Accessed March 22, 2009.
4. Ridker PM. C-reactive protein: a simple test to help predict risk of heart attack and stroke [published online ahead of print September 23, 2003]. Circulation. 2003;108(12):e81-e85. http://circ.ahajournals.org/cgi/reprint/108/12/e81. Accessed March 22, 2009.
5. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels [published online ahead of print November 5, 1998]. N Engl J Med. 1998;339(19):1349- 1357. http://content.nejm.org/cgi/reprint/339/19/1349.pdf. Accessed March 18, 2009.
6. Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KAA, Granger CB, et al; the GRACE Investigators. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE studym [published online ahead of print June 1, 2004]. Ann Intern Med. 2004;140(11):857-866. http://www.annals.org/cgi/reprint/140/11/857.pdf. Accessed March 18, 2009.
7. Mann D, Reynolds K, Smith D, Munter P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines [published online ahead of print July 22, 2008]. Ann Pharmacother. 2008;42(9):1208-1215. http://www.theannals.com/cgi/reprint/42/9/1208. Accessed March 20, 2009.
8. Ma J, Sehgal NL, Ayanian JZ, Stafford RS. National trends in statin use by coronary heart disease risk category. PLoS Med. 2005;2:e123. http://medicine.plosjournals.org/archive/1549-1676/2/5/pdf/10.1371_journal.pmed.0020123-L.pdf. Accessed March 9, 2009.
9. Nelson K, Norris K, Mangione CM. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey [published online ahead of print April 22, 2002]. Arch Intern Med. 2002;162(8):929-935. http://archinte.amaassn.org/cgi/reprint/162/8/929. Accessed March 9, 2009.
10. Massing MW, Foley KA, Carter-Edwards L, Sueta CA, Alexander CM, Simpson RJ Jr. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study [published online ahead of print August 18, 2004]. BMC Cardiovasc Disord. 2004;4:15. http://www.biomedcentral.com/1471-2261/4/15. Accessed March 2, 2009.
11. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Ambulatory health care data. http://www.cdc.gov/nchs/ahcd.htm. Accessed June 10, 2010.
12. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Ambulatory health care data. http://www.cdc.gov/nchs/ahcd.htm. Accessed June 10, 2010. 12. ICD-9-CM: International Classification of Diseases, 9th revision, Clinical Modification. 5th ed. Salt Lake City, UT: Medicode; 1997.
13. Varma R, Aronow WS, Gandelman G, Zammit C. Prevalence of adequate control of increased serum low-density lipoprotein cholesterol in self-pay or Medicare patients versus Medicaid or private insurance patients followed in a university general medicine clinic. Am J Cardiol. 2005;95(2):269-270.
14. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Health, United States, 2008. http://www.cdc.gov/nchs/data/hus/hus08.pdf. Accessed March 15, 2009.